This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Lupus Foundation Of America Recognizes Top Researchers With Prestigious Evelyn V. Hess Award And Mary Betty Stevens Prize

Dr. Ellen M. Ginzler Honored With Hess Award; Dr. Diane Leigh Kamen Receives Stevens Prize for Contributions to Lupus Research

WASHINGTON, Nov. 12, 2012 /PRNewswire-USNewswire/ -- The Lupus Foundation of America bestowed its top honors on two leading scientists for their exceptional achievements in lupus research, at its annual awards reception held tonight at the Newseum in Washington. Ellen M. Ginzler, M.D., M.P.H. was awarded the prestigious 2012 Evelyn V. Hess, M.D., M.A.C.P., M.A.C.R., Research Award, that the Lupus Foundation of America presents annually to a researcher who has made outstanding contributions to the field of lupus research, diagnosis, and treatment. Diane Leigh Kamen, M.D., M.S.C.R., was awarded the 2012  Mary Betty Stevens, M.D., Young Investigator Prize for her early contributions to the field.

(Logo: http://photos.prnewswire.com/prnh/20120711/DC38337LOGO)

The reception was hosted by the Lupus Foundation of America's National Board of Directors. Dr. Ginzler is the Division Chief of Rheumatology at the State University of New York's Downstate Medical Center while Dr. Kamen is an Assistant Professor of Medicine in the Division of Rheumatology at the Medical University of South Carolina (MUSC).

Dr. Ginzler is internationally known as an expert on lupus nephritis, which occurs when lupus causes inflammation in the kidneys, making them unable to properly remove waste from the blood or control the amount of fluids in the body.

As principal investigator of an Orphan Products Program grant awarded by the Food and Drug Administration to assess the efficacy and tolerability of two drug treatments for lupus nephritis, Dr. Ginzler headed the largest multicenter, investigator-initiated trial ever carried out at that time for lupus. The results, published as the lead article in the  New England Journal of Medicine in 2005 , have changed the paradigm for treating lupus nephritis. Dr. Ginzler is a Master of the American College of Rheumatology and a fellow of the American College of Physicians, and was a long-time member of the Board of Governors of the New York Chapter of the Arthritis Foundation.

The Lupus Foundation of America established the annual Hess award in 2005 to honor Dr. Hess for her outstanding contributions to lupus research over the course of her long career. The award is given annually to a clinical or basic researcher whose body of work has advanced understanding of the pathophysiology, etiology, epidemiology, diagnosis, or treatment of lupus.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs